These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8851586)

  • 1. Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucks.
    Rajagopalan P; Boudinot FD; Chu CK; Tennant BC; Baldwin BH; Schinazi RF
    Antimicrob Agents Chemother; 1996 Mar; 40(3):642-5. PubMed ID: 8851586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks.
    Witcher JW; Boudinot FD; Baldwin BH; Ascenzi MA; Tennant BC; Du JF; Chu CK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2184-7. PubMed ID: 9333045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies scaling and pharmacokinetic parameters of 3TC in humans.
    Hussey EK; Donn KH; Daniel MJ; Hall ST; Harker AJ; Evans GL
    J Clin Pharmacol; 1994 Oct; 34(10):975-7. PubMed ID: 7530728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans.
    Hurwitz SJ; Tennant BC; Korba BE; Gerin JL; Schinazi RF
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2804-9. PubMed ID: 9797207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
    Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
    Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Seasonal Pharmacokinetic Variability in Woodchucks.
    Zheng J; Balsitis S; Santos R; Smith BJ; Subramanian R
    Drug Metab Dispos; 2020 Nov; 48(11):1199-1209. PubMed ID: 32892154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE; Schinazi RF; Cote P; Tennant BC; Gerin JL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
    Frick LW; St John L; Taylor LC; Painter GR; Furman PA; Liotta DC; Furfine ES; Nelson DJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2285-92. PubMed ID: 8285607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
    Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
    Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.
    Zhou T; Saputelli J; Aldrich CE; Deslauriers M; Condreay LD; Mason WS
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1947-54. PubMed ID: 10428918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of lamivudine in cats.
    Zhang W; Mauldin JK; Schmiedt CW; Brockus CW; Boudinot FD; McCrackin SM
    Am J Vet Res; 2004 Jun; 65(6):841-6. PubMed ID: 15198226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.